More Entrants into Veterinary Diagnostics Expected

At nearly USD 2 billion dollars, veterinary diagnostics represent an ancillary but increasingly appealing course of market development for companies active in the USD 55 billion in vitro diagnostics (IVD) market, according to Kalorama Information (New York, NY, USA)

Analysis of the veterinary in vitro diagnostics (IVD) segment by the Kalorama Information indicates that in the United States there have been recent market entrants and product introductions for the companion or pet segment of the market. In contrast, stable epidemiological factors among US livestock did not result in much expansion of the food animal diagnostics market.

Since 2012, new market players for animal disease test kits in the United States include Biogal/Galed Laboratories, Princeton BioMeditech, and InBios. These companies have launched approved tests for canine distemper, canine heartworm, and West Nile virus. Overall, nearly half of the infectious disease tests introduced between 2012 and 2014 in the United States were for companion animal diseases, disproportionate to the significantly wider portfolio of livestock disease tests. Companion animal diagnostics continues to represent the more attractive market opportunity and segment in veterinary diagnostics.

“New entrants to veterinary IVD are to be expected due to the low technical and regulatory market barriers and recent superior market performance to clinical IVD,” report analyst Emil Salazar related. “But this has played out especially in pet diagnostics where growth has ridden increasing consumer spending on pets, especially on pet health care.”

The analyst also said, “Future veterinary diagnostics market growth will depend upon the development of markets for more sophisticated products such as molecular diagnostic tests and increasing testing intensity as instrument placements decline in saturated markets.”

The United States has not supported as robust a food animal diagnostics market as Europe, where several disease eradication programs boosted livestock testing in the past decade. In the review of new products introduced to the US veterinary diagnostics market between 2012 and 2014, Kalorama Information found 14 livestock infectious disease tests delisted (as part of portfolio management or company withdrawal from the market) and 9 introduced (in most cases with competitive tests already on the market). Three of the delisted tests were from vendors still offering another test product for the same target disease. The near equal rates of product addition and attrition indicate a largely static market for US livestock infectious disease diagnostics. Market growth is predicated upon disease outbreaks and management; the United States has seen no recent, market-significant outbreaks, and active disease eradication programs have focused overwhelmingly on industry practices and vaccination.

Kalorama Information’s report, The World Market for Veterinary Diagnostics, provides more information including breakouts for various segments of veterinary diagnostics, and discussions of trends in the industry. Profiles of key competitors are also included.

Kalorama Information, a division of MarketResearch dot com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services.

Related Links:
Kalorama Information